FDA.reportPublic FDA data

tiletamine 50 MG/ML / zolazepam 50 MG/ML Injectable Solution [Telazol]

RxCUI
1535261
RxNorm name
tiletamine 50 MG/ML / zolazepam 50 MG/ML Injectable Solution [Telazol]
Display name
tiletamine 50 MG/ML / zolazepam 50 MG/ML Injectable Solution [Telazol]
Full name
tiletamine 50 MG/ML / zolazepam 50 MG/ML Injectable Solution [Telazol]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3ef51363-2236-40aa-bf32-601c9f1c722aTelazol 50 MG/ML / 50 MG/ML Injectable Solution [PSN] · tiletamine 50 MG/ML / zolazepam 50 MG/ML Injectable Solution [Telazol] [SBD] · tiletamine (as tiletamine hydrochloride) 50 MG/ML / zolazepam (as zolazepam hydrochloride) 50 MG/ML Injectable Solution [Telazol] [SY]36Telazol ® CIII (tiletamine and zolazepam for injection)20230911